The Nephrology section combines the delivery of outstanding clinical services with world-class research. An integrated team of physicians, nurse practitioners, and nurse clinicians addresses the most pressing needs facing cancer patients with kidney diseases. Physicians will provide continuity of care following discharge of patients.
Although kidney disease is very common in patients with cancer, most nephrology trainees have little exposure during their fellowship to several renal syndromes that are unique to patients with cancer, including conditions caused by the cancer itself and by its treatment. MD Anderson's Onco-Nephrology Fellowship provides experience in the management of unique problems in cancer patients such as nephrotoxicity from traditional chemotherapy as well as targeted therapy, renal disease after stem cell transplant, myeloma related kidney disease, paraneoplastic renal disease, and electrolyte disorders secondary to cancer or cancer therapy. Trainees will also gain experience in critical care nephrology and renal replacement therapy, as well as in the psychosocial aspects of renal replacement therapy during near-end of life care. Visit the Onco-Nephrology Fellowship page for more information on the program.
- Farhad Danesh, M.D., Professor and Section Chief
- Amit Lahoti, M.D., Associate Professor
- Sheldon Chen, M.D., Associate Professor
- Biruh Workeneh, M.D., Associate Professor
- Ala Abudayyeh, M.D., Assistant Professor
- Kenneth Ward, Advanced Practice Registered Nurse
Visit the Danesh Laboratory page for more information on nephrology research.
Farhad Danesh, M.D., Professor and Section Chief, Nephrology
Grecia Alvarado-Fuentes | Sr. Administrative Assistant
PO Box 301402, Unit 1468
Houston, TX 77230-1402
1400 Pressler Street, FCT13.6082
Houston, TX 77030-3722